Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis.
Ruder S, Gao Y, Ding Y, Bu P, Miles B, De Marzo A, Wheeler T, McKenney JK, Auman H, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave M, Platz E, Trock B, Han M, Sayeeduddin M, True LD, Rowley D, Lin DW, Nelson PS, Thompson IM, Feng Z, Wei W, Brooks JD, Ittmann M, Lee M, Ayala G.
Ruder S, et al.
Hum Pathol. 2022 Apr;122:84-91. doi: 10.1016/j.humpath.2022.01.009. Epub 2022 Feb 15.
Hum Pathol. 2022.
PMID: 35176252
Free PMC article.